Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Filed with HKEX · Stock code 3933 · · 10 pages · English
Summary by 6ix AI
It confirms the total authorized and registered share capital at the end of the month. The report also includes information on issued shares and public float sufficiency confirmation. The issuer confirms compliance with applicable listing rules and regulatory requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
United Laboratories International Holdings Ltd. on 6ix
Earlier from United Laboratories International
- Second milestone payment from novo for exclusive license agreement of UBT251
- Notification Letter to Non-register Holder and Reply Form
- Notification Letter to Shareholder and Reply Form
- 2026 Interim report
- The group's product insulin degludec and liraglutide injection marketing registration application been accepted
Follow United Laboratories International into a list and get an email when it puts out news.
Follow United Laboratories International